<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0000147'>Polycystic ovary</z:hpo> syndrome (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCOS</z:e>) is one of the most common <z:chebi fb="32" ids="24621">endocrine</z:chebi> disorders in women </plain></SENT>
<SENT sid="1" pm="."><plain>It is characterized by <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0008869'>anovulation</z:mp>, <z:e sem="disease" ids="C0206081" disease_type="Disease or Syndrome" abbrv="">hyperandrogenism</z:e>, <z:hpo ids='HP_0001513'>obesity</z:hpo> and a predisposition to type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (T2DM) </plain></SENT>
<SENT sid="2" pm="."><plain>Since <z:hpo ids='HP_0001513'>obesity</z:hpo> plays an important role in the etiology of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCOS</z:e>, we sought to determine if variants in the perilipin gene (PLIN), a gene previously implicated in the development of <z:hpo ids='HP_0001513'>obesity</z:hpo>, were also associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCOS</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>We typed six single nucleotide polymorphisms (haplotype tagging and/or previously associated with <z:hpo ids='HP_0001513'>obesity</z:hpo> or related metabolic traits) in PLIN in 305 unrelated non-Hispanic white women (185 with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCOS</z:e> and 120 without <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCOS</z:e>) </plain></SENT>
<SENT sid="4" pm="."><plain>None of the variants was associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCOS</z:e> (P&lt;0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>However, the variant rs1052700*A was associated with increased risk for <z:hpo ids='HP_0000833'>glucose intolerance</z:hpo> (<z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> or T2DM) in both non-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCOS</z:e> (OR=1.75 [1.02-3.01], P=0.044) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCOS</z:e> subjects (OR=1.67 [1.08-2.59], P=0.022) </plain></SENT>
<SENT sid="6" pm="."><plain>It was also associated with increased <z:chebi fb="15" ids="39026">LDL</z:chebi> (P=0.007) and total cholesterol levels (P=0.042) </plain></SENT>
<SENT sid="7" pm="."><plain>These results suggest that genetic variation in PLIN may affect <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism in women both with and without <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCOS</z:e> </plain></SENT>
</text></document>